MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

H1/H2 MAPT Haplotype and Parkinson’s Disease in an Ashkenazi Jewish Cohort

G. Yahalom, L. Greenbaum, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, S. Hassin-Baer, Z. Gan-Or, J. Ruskey, E. Leveille, U. Rudakou, L. Krohn, G. Rouleau (Jerusalem, Israel)
Hand Fine Motor Performance Capacity is Associated with the Cognition in People with Moderate to Advanced Parkinson’s disease

S. Tan, C.T Hong, T.H Liou (New Taipei City, Taiwan)
Hardware-related complications and relevant treatment for deep brain stimulation: Experience of 1157 patients at Ruijin Hospital over 8 years

T. Wang, D. Su, C. Zhang, Y. Pan, P. Huang, S. Zhan, L. Bian, B. Sun, D. Li (Shanghai, China)
HD Constellation: A novel patient-centred approach to enriching clinical datasets by combining medical record chart review and Enroll-HD

K. Belendiuk, J.P Sacksteder, X. Sanii, E. Neacy, J. Levey, E. Korner, R. Houghton, G. Yohrling (South San Francisco, CA, USA)
Health care provision and health related quality of life in late stage Parkinson’s disease

K. Rosqvist, P. Odin, A. Schrag (Lund, Sweden)
Healthcare resource utilisation and costs among patients with versus without Huntington’s disease in the US population

A. Exuzides, T.M To, I. Abbass, A. Surinach, R. Fuller, J. Luo (South San Francisco, CA, USA)
Healthcare Utilization and Cost Burden at the End-of-Life Among Medicare Beneficiaries with Huntington’s Disease

S. Reddy, A. Exuzides, E. Chang, C. Paydar, G. Yohrling (Beverly Hills, CA, USA)
Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study

A.H Tan, S.Y Lim, S. Mahadeva, M.F Loke, J.S Vadivelu, C. Marras, S.H Fox, A.E Lang (Kuala Lumpur, Malaysia)
Hereditary spastic paraparesis plus syndrome associated to a novel FARS2 gene mutation

C. González Robles, M. Novillo, J.M Mesa Latorre, J.L López-Sendón Moreno, A. Jiménez-Escrig, A. Rojo Sebastián (Alcala de Henares, Spain)
Heterozygous mutation in CCDC88C gene as a cause of early onset pure hereditary spastic paraplegia

A. Mohamed, S. Emad, R. Adil, L. Elsayed, A. Ahmed, G. Stevanin (Khartoum, Sudan)
High levodopa plasma concentration in the acute levodopa challenge test predicts levodopa-induced dyskinesia in Parkinson’s disease

T. Shiraishi, N. Nishikawa, Y. Mukai, Y. Takahashi (Kodaira-shi, Tokyo, Japan)
High prevalence of REM sleep behavior disorder (RBD) in advanced, fluctuating Parkinson’s disease (PD) patients: comparison of clinical parameters between PD patients with and without RBD

M.L Muntean, F. Sixel-Döring, C. Trenkwalder (Kassel, Germany)
High Satisfaction and Improved Quality of Life with Rock Steady Boxing in Parkinson’s Disease

D. Larson, D. Bega, M. Rafferty, C. Yeh (Chicago, IL, USA)
High-frequency rTMS over the primary motor cortex relieves musculoskeletal pain in Parkinson’s disease: A randomized controlled trial

J. Li, T. Mi, W. Mao, J. Ma, P. Chan (Beijing, China)
Higher adherence to MIND diet associated with later onset of Parkinson’s disease

A. Metcalfe-Roach, M. Cirstea, A. Yu, E. Golz, K. Sundvick, D. Kliger, B. Finlay, S. Appel-Cresswell (Vancouver, BC, Canada)
Higher exercise self-efficacy is a predictor of clinically meaningful walking activity change in people with Parkinson disease

C. Colon-Semenza, J. Zajac, T. DeAngelis, T. Ellis (Boston, MA, USA)
Higher grey matter aging in multiple system atrophy than Parkinson’s disease

M.C Kuo, C.L Chen, C.H Tai, W.Y Tseng, R.M Wu (Taipei, Taiwan)
Holmes tremor (HT) associated with brainstem cavernous venous malformation (cavernoma) and acute hydrocephalus

I. Sudath, I. Rajapakshe, B. Senanayake (colombo 07, Sri Lanka)
Home Based Care: A care pathway innovation for Parkinson’s disease

E. Edwards, R. Partridge, U. Ankeny, J. Langley, S. Whipps, J. Whipps, J. Rideout, A. Evans, S. Bentley, M. Swabey, H. Matthews, N. Stevens, R. Chivers, T. Dominey, K. Triscott, C. Carroll (Plymouth, United Kingdom)
Home validation of a smartphone-based tapping task to assess medication responsiveness in Parkinson’s disease

S. Broeder, R. Bussels, S. Vanden Schoor, G. Roussos, J-J. Orban deXivry, A. Nieuwboer (Leuven, Belgium)
Home videos made on smart phone supplements paper based diary for correct identification of Motor states in Parkinson’s disease

D. Dash, R. Singh, D. Vibha, M. Tripathi (Delhi, India)
Homer1 polymorphism in patients with Parkinson’s disease and psychosis

A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal (Washington, DC, USA)
Hospitalization causes and condition at discharge of Parkinson’s disease patients in Mexican public institutions between 2011 and 2017

R. Janssen-Aguilar, V. Villasuso-Alcocer, C. Rivas-Berny, N. Méndez-Domínguez, R. Leal-Ortega (Mérida, Mexico)
How cultural beliefs buffer against suicide in Parkinson’s disease patients with Depression: An Indian Karmic Perspective

A. Nehra, A. Srivastava, R. Rajan, R. Singh, M. Khan, P. Sharma, A. Narain (Delhi, India)
How does the perception of fall risk influence behavior in people with Parkinson’s disease?

Y. Huang, J. Song, L. Clemson, N. Allen (Lidcombe, Australia)
How Parkinson’s Disease Affects Working Memory

L. Montaser Kouhsari, A. Bakkour, D. Shohamy (New York, NY, USA)
How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?

C. Snell, H. Smith, J. Castleton, A. Hall, A. Smirnova, B. Wright, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)
hUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk

J. Li, H.L Wang, M.W Wang (Shijiazhuang, China)
Human induced pluripotent stem cells (iPSCs) as a model for the study of neural development in Parkinson’s Disease patients carrying GBA mutations

F. Motolese, A. Casamassa, A. Vescovi, V. Di Lazzaro, J. Rosati, M. Marano (Rome, Italy)
Human STN local field potentials recording and stimulation and sleep response in Parkinson’s disease after deep brain stimulation

M. Ferreira-Pinto, A. Oliveira, C. Chamadoira, R. Vaz, J. Massano (Porto, Portugal)
Huntington’s disease in Egypt; A big challenge for a mysterious disease

S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)
Huntington’s Disease in Israel – 20 years of follow up from Maccabi Healthcare Services

Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)
Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders

C.H Tai, S.H Tseng, T.R Wang, M.T Hsu, C-C. Kuo (Taipei, Taiwan)
Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z